AlphaRx Inc. (ALRX) and Gaia BioPharma Secure Phase I/II Manufacturer For GAI-122 and unveil Their Clinical Development Strategy
1/21/2010 9:39:47 AM
More...
|
AlphaRx Inc. (ALRX) and Gaia BioPharma Secure Phase I/II Manufacturer for GAI-122 and Unveil Their Clinical Development Strategy
1/21/2010 9:07:23 AM
More...
|
AlphaRx Inc. (ALRX)'s Newly Appointed President of China Operations Unveils Strategic Corporate Initiatives
12/21/2009 10:12:08 AM
More...
|
AlphaRx Inc. (ALRX) Signs Contract Manufacturing Agreement for ARX1088
12/17/2009 8:35:28 AM
More...
|
AlphaRx Inc. (ALRX) Appoints President for its China Operations
12/14/2009 9:50:36 AM
More...
|
AlphaRx Inc. (ALRX) Establishes Corporate Headquarters in Hong Kong and R&D Facility in Shanghai
12/3/2009 6:30:37 AM
More...
|
AlphaRx Inc. (ALRX) and Riso Pharma Sign Collaboration and Licensing Agreement
9/30/2009 9:01:07 AM
More...
|
AlphaRx Inc. (ALRX) Presents Company Overview and New Product Candidates at the Rodman & Renshaw Healthcare Conference
9/14/2009 9:26:55 AM
More...
|
AlphaRx Inc. (ALRX) to Present at Rodman & Renshaw Annual Global Investment Conference
9/3/2009 11:16:50 AM
More...
|
AlphaRx Inc. (ALRX) Concludes GAI-122 Formulation Development Intended For The Prevention of Delirium
8/27/2009 9:18:09 AM
More...
|
|